Pfizer reported first-quarter 2025 earnings on Tuesday that beat Wall Street expectations, boosted by ongoing cost-cutting ...

Shares of US clinical-stage biotech Biohaven (NYSE: BHVN) rose 9.6% to $21.74 yesterday, after it announced an agreement with ...

Italian pharma major Recordati (RECI: MI) has set new three-year financial targets for the period 2025-2027, aiming for ...

Granite Bio AG, a clinical-stage immunology company based in Basel, Switzerland, and San Francisco, California, emerged from ...

Early-stage biotech Nova Anchora has secured a new investment to move its lead therapy for epidermolysis bullosa (EB) closer ...

AstraZeneca posted a 10% rise in first-quarter revenue to $13.6 billion, supported by strong sales of cancer drugs and ...

Swiss pharma giant Novartis (NOVN: VX) this morning posted first-quarter 2025 financials, showing that net sales were $13.2 ...

Regeneron Pharmaceuticals (Nasdaq: REGN) today announced that the European Commission (EC) has granted conditional marketing ...

The USA faces a serious risk of measles becoming endemic again, according to a new study modeling the impact of declining ...

The Novo Nordisk Foundation has opened its largest research funding initiative, the Challenge Programme, to applicants based outside Denmark for the first time, allowing researchers from the European ...

USA-based Medicus Pharma (Nasdaq: MDCX) has agreed to acquire UK firm Antev for around $75 million in a share exchange deal.